HomeCompareMLCT vs PLD

MLCT vs PLD: Dividend Comparison 2026

MLCT yields 1025.64% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLCT wins by $23506537.02M in total portfolio value
10 years
MLCT
MLCT
● Live price
1025.64%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23506543.53M
Annual income
$19,723,609,349,823.79
Full MLCT calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — MLCT vs PLD

📍 MLCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLCTPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLCT + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLCT pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLCT
Annual income on $10K today (after 15% tax)
$87,179.49/yr
After 10yr DRIP, annual income (after tax)
$16,765,067,947,350.22/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, MLCT beats the other by $16,765,063,479,379.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLCT + PLD for your $10,000?

MLCT: 50%PLD: 50%
100% PLD50/50100% MLCT
Portfolio after 10yr
$11753275.02M
Annual income
$9,861,807,303,129.99/yr
Blended yield
83.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MLCT
No analyst data
Altman Z
-1.8
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLCT buys
0
PLD buys
0
No recent congressional trades found for MLCT or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLCTPLD
Forward yield1025.64%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$23506543.53M$6.50M
Annual income after 10y$19,723,609,349,823.79$5,256,436.18
Total dividends collected$23218513.75M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MLCT vs PLD ($10,000, DRIP)

YearMLCT PortfolioMLCT Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$113,264$102,564.10$11,255$555.24+$102.0KMLCT
2$1,206,878$1,085,685.14$13,062$1,018.59+$1.19MMLCT
3$12,102,987$10,811,628.23$15,903$1,926.67+$12.09MMLCT
4$114,279,868$101,329,670.98$20,839$3,823.32+$114.26MMLCT
5$1,016,469,856$894,190,397.43$30,464$8,166.08+$1016.44MMLCT
6$8,520,740,273$7,433,117,527.67$52,054$19,457.30+$8520.69MMLCT
7$67,350,310,269$58,233,118,176.66$109,886$54,188.93+$67350.20MMLCT
8$502,243,173,894$430,178,341,906.41$304,030$186,451.18+$502242.87MMLCT
9$3,535,452,502,858$2,998,052,306,790.74$1,166,125$840,813.32+$3535451.34MMLCT
10$23,506,543,527,881$19,723,609,349,823.79$6,504,190$5,256,436.18+$23506537.02MMLCT

MLCT vs PLD: Complete Analysis 2026

MLCTStock

Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.

Full MLCT Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MLCT vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLCT vs SCHDMLCT vs JEPIMLCT vs OMLCT vs KOMLCT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.